SIDDHA DRUG ATTHI PINCHU ENNAI TRIAL FOR RATTHA MOOLAM(HAEMORRHOIDS) DISEASE

AN OPEN PILOT CLINICAL STUDY ON RATTHA MOOLAM (HAEMORRHOIDS) WITH THE EVALUATION OF TRIAL DRUG ATTHI PINCHU ENNAI

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/07/004773

Enrollment

Registered

2014-07-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Painless bleeding during defaecation

Interventions

Intervention1: ATTHI PINCHU ENNAI: 15MI. 15 DAYS , TWICE A DAY

Eligibility

Inclusion criteria

Inclusion criteria: Patients with appropriate symptoms like, Painless bleeding during defaecation, Constipation, Loss of appetite, Pain around umbilicus, Anaemia, Associate symptoms are Pain in the limbs, Headache giddiness, tiredness

Exclusion criteria

Exclusion criteria: Below 12 Years 2. Pregnant and lactating women 3. External heamorrhoids 4. Fissure in ano 5. Secondary heamorrhoids 6. Fistula 7. CA Rectum

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduction in clinical symptomsTimepoint: comparing clinical symptoms before and after treatment.	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameterss before and after treatmentTimepoint: NIL	—

Countries

India

Contacts

Public ContactDrRVADIVELAN

Govt.Siddha Medical College, Chennai. Tamil Nadu

drkkanakavalli@gmail.com9962047787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026